Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | CA12 | O43570 | 2/20 | 0.32 |
| ▸ | CA1 | P00915 | 2/20 | 0.32 |
| ▸ | CA9 | Q16790 | 2/20 | 0.32 |
| ▸ | CES1 | P23141 | 1/20 | 0.31 |
| ▸ | MMP1 | P03956 | 1/20 | 0.31 |
| ▸ | MMP2 | P08253 | 1/20 | 0.31 |
| ▸ | MMP3 | P08254 | 1/20 | 0.31 |
| ▸ | MMP8 | P22894 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL886851 | 0.85 | ALDH1A1 (0.44) | LMNAALDH1A1CA12CA1CA9 | |
| SCHEMBL662739 | 0.82 | LMNA (0.48) | LMNAALDH1A1HSD17B10 | |
| SCHEMBL28535905 | 0.79 | ALDH1A1 (0.43) | ALDH1A1CA12CA1CA9CES1 | |
| SCHEMBL11316939 | 0.77 | ALDH1A1 (0.41) | ALDH1A1CES1HSD17B10 | |
| SCHEMBL11324311 | 0.77 | ALDH1A1 (0.41) | ALDH1A1CES1HSD17B10 | |
| SCHEMBL11317529 | 0.77 | ALDH1A1 (0.41) | ALDH1A1CES1HSD17B10 | |
| SCHEMBL190924 | 0.77 | ALDH1A1 (0.41) | ALDH1A1CES1HSD17B10 | |
| SCHEMBL6848043 | 0.76 | LMNA (0.50) | LMNAALDH1A1HSD17B10 | |
| 1-Hexanol SCHEMBL29163470 | 0.75 | ALDH1A1 (0.48) | LMNAALDH1A1CES1HSD17B10 | |
| 1-Heptanol SCHEMBL29163446 | 0.75 | ALDH1A1 (0.48) | LMNAALDH1A1CES1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210085633-A1 | RIVASTIGMINE-CONTAINING TRANSDERMAL ABSORPTION PREPARATION | TEIKOKU SEIYAKU CO., LTD. (JP) | 2021-03-25 | — | — | US | disclosed |
| EP-3656383-A1 | RIVASTIGMINE-CONTAINING PERCUTANEOUS ABSORPTION-TYPE PREPARATION | Teikoku Seiyaku Co., Ltd. (JP) | 2020-05-27 | — | — | EP | disclosed |
| US-20040028724-A1 | Pharmaceutical preparation of percutaneous absorption type | HISAMITSU PHARMACEUTICAL CO., INC. (JP) | 2004-02-12 | — | — | US | disclosed |
| EP-1340496-A1 | PHARMACEUTICAL PREPARATION OF PERCUTANEOUS ABSORPTION TYPE | HISAMITSU PHARMACEUTICAL CO. INC. (JP) | 2003-09-03 | — | — | EP | disclosed |